Advanced search
Publication Cover
Expert Opinion on Investigational Drugs Volume 22, 2013 - Issue 9
Submit an article Journal homepage
2,331
Views
6
CrossRef citations to date
0
Altmetric
Editorial

Statins and nonalcoholic fatty liver disease: a bright future?

Vasilios G AthyrosAristotle University of Thessaloniki, Hippokration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece
,
Niki KatsikiAristotle University of Thessaloniki, Hippokration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece
,
Asterios KaragiannisAristotle University of Thessaloniki, Hippokration Hospital, Medical School, Second Propedeutic Department of Internal Medicine, Thessaloniki, Greece
&
Dimitri P MikhailidisAcademic Head, University College London (UCL), Royal Free Hospital Campus, University College London Medical School, Department of Clinical Biochemistry, Pond Street, London NW3 2QG, UK+44 20 7830 2258; +44 20 7830 2235; [email protected]
, MD FFPM FRCP FRCPath
Pages 1089-1093 | Published online: 29 Jul 2013

Citations (6)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (1)

Vasilios G. Athyros, Niki Katsiki, Asterios Karagiannis & Dimitri P. Mikhailidis. (2014) Are statins ‘IDEAL’ for non-alcoholic fatty liver disease?. Current Medical Research and Opinion 30:2, pages 229-231.
Read now

Articles from other publishers (5)

Hyo Young Lee, Dae Won Jun, Hyun Jung Kim, Hyunwoo Oh, Waqar Khalid Saeed, Hyeongsik Ahn, Ramsey C. Cheung & Mindie H. Nguyen. (2019) Ezetimibe decreased nonalcoholic fatty liver disease activity score but not hepatic steatosis. The Korean Journal of Internal Medicine 34:2, pages 296-304.
Crossref
Linda Ban, Nicholas Shackel & Susan McLennan. (2016) Extracellular Vesicles: A New Frontier in Biomarker Discovery for Non-Alcoholic Fatty Liver Disease. International Journal of Molecular Sciences 17:3, pages 376.
Crossref
Vasilios G Athyros, Konstantinos Tziomalos, Niki Katsiki, Michael Doumas, Asterios Karagiannis & Dimitri P Mikhailidis. (2015) Cardiovascular risk across the histological spectrum and the clinical manifestations of non-alcoholic fatty liver disease: An update. World Journal of Gastroenterology 21:22, pages 6820-6834.
Crossref
Aris P. Agouridis & Dimitri P. Mikhailidis. 2015. Combination Therapy In Dyslipidemia. Combination Therapy In Dyslipidemia 37 43 .
Catherine E. de Keyser, Edith M. Koehler, Jeoffrey N.L. Schouten, Loes E. Visser, Albert Hofman, Harry L.A. Janssen & Bruno H. Stricker. (2014) Statin therapy is associated with a reduced risk of non-alcoholic fatty liver in overweight individuals. Digestive and Liver Disease 46:8, pages 720-725.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.